New insider activity at Incyte ( (INCY) ) has taken place on July 23, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EVP & Chief Medical Officer Steven H Stein recently sold 3,706 shares of Incyte stock, amounting to a total transaction value of $251,785.
Spark’s Take on INCY Stock
According to Spark, TipRanks’ AI Analyst, INCY is a Outperform.
Incyte’s overall stock score reflects its solid financial position and strong earnings call performance. The company’s robust revenue growth and strategic initiatives are significant strengths. However, high valuation metrics and potential competition pose risks. Recent corporate events provide operational flexibility but also immediate financial impacts.
To see Spark’s full report on INCY stock, click here.
More about Incyte
YTD Price Performance: -0.91%
Average Trading Volume: 1,850,564
Technical Sentiment Signal: Buy
Current Market Cap: $13.34B